• Thu, April 4, 2024
Charles Duncan Reiterated (ATAI) at Buy on, Apr 4th, 2024
Charles Duncan of Cantor Fitzgerald, Reiterated "Atai Life Sciences N.V." (ATAI) at Buy on, Apr 4th, 2024.
Charles has made no other calls on ATAI in the last 4 months.
There are 2 other peers that have a rating on ATAI. Out of the 2 peers that are also analyzing ATAI, 0 agree with Charles's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Charles
- Jason McCarthy of "Maxim Group" Upgraded from Hold to Strong Buy and Held Target at $6 on, Wednesday, April 3rd, 2024
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $15 on, Wednesday, April 3rd, 2024